Quantcast
Channel: benefit – THE "NEW" PROSTATE CANCER INFOLINK
Browsing latest articles
Browse All 28 View Live

Image may be NSFW.
Clik here to view.

“Psychosocial interventions in prostate cancer offer limited benefits”

The heading above is the title of a Reuters-generated article on the Medcape Oncology web site. The article is based on a new review article just published in BJU International. Parahoo et al. carried...

View Article


Image may be NSFW.
Clik here to view.

Assessing the “value” of new drugs in the treatment of [prostate] cancer

Yesterday the American Society of Clinical Oncology (ASCO) issued the initial draft of “a conceptual framework for assessing the value of new cancer therapies based on treatment benefits, toxicities,...

View Article


Image may be NSFW.
Clik here to view.

USPSTF to re-assess harms and benefits of PSA-based screening for risk of...

Yesterday the U.S. Preventive Services Task Force (USPSTF) posted detailed information about a new draft research plan related to screening for prostate cancer. The USPSTF is seeking public comment on...

View Article

Image may be NSFW.
Clik here to view.

Testosterone treatment in aging men with hypogonadism

Testosterone levels tend to fall in most men as we age. This is hardly new information! An article this week in the New England Journal of Medicine suggests that treatment with testosterone gels is...

View Article

Image may be NSFW.
Clik here to view.

And back to the screening controversy, yet again …

Four very recent articles and presentations have addressed issues relevant to the use of the PSA test in testing/screening for risk of prostate cancer. An extremely detailed article by Roth et al. in...

View Article


Image may be NSFW.
Clik here to view.

New immunotherapeutics aren’t working well when combined with standard forms...

A newly published article in the journal Science Translational Medicine has questioned the merits of treating prostate cancer patients with immunotherapies while they are simultaneously being treated...

View Article

Image may be NSFW.
Clik here to view.

And now … data from the PCLO trial at 15 years …

A new update on the prostate cancer outcomes of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial has given us a rather different interpretation of the meaning of the data from...

View Article

Image may be NSFW.
Clik here to view.

Kaiser reports on quality of life outcomes after first-line treatment for...

Kaiser Permanente maintains a large data registry in  order to assess the quality of outcomes over time among tens of thousands of Kaiser patients, prostate cancer patients included. In the current...

View Article


Image may be NSFW.
Clik here to view.

An update on “screening” for prostate cancer: four perspectives

To quote the abstract of the paper discussed below, the use of the PSA test to screen for risk of prostate cancer “in men at normal risk of prostate cancer is one of the most contested issues in cancer...

View Article


Image may be NSFW.
Clik here to view.

Patients’ understanding of the risks and benefits of first-line treatment

A newly published article in BJU International has (finally) proven something many prostate cancer educators and advocates have known for years: many patients have a very poor appreciation of the risks...

View Article

Are we all talking about AS the same way? Not yet!

An interesting new article in The ASCO Post tells us almost as much about the physicians who treat prostate cancer as it does about the options that are available to patients. Unfortunately, articles...

View Article

Prostate ablation using HIFU — the role of patient preference information

A newly published review by staff of the Center for Devices and Radiological Health (CDRH at the U.S. Food & Drug Administration (FD) addresses the potential role for patient preference information...

View Article

Survival of men with metastatic, castration-resistant prostate cancer

There has been regular discussion here and elsewhere about the degree to which new forms of therapy have impacted patient survival since the original approval of docetaxel for treatment of metastatic,...

View Article


The pros and cons of “screening” for prostate cancer

A newly published article by Shoag et al. in the New England Journal of Medicine (NEJM) has suggested that the risks associated with “screening” for prostate cancer using the PSA test may not be as...

View Article

How does your doctor do prostate biopsies?

So (in our opinion) the time has come — for a whole bunch of reasons — for actual and potential prostate cancer patients to start asking their urologists about whether they are able to carry out...

View Article

Browsing latest articles
Browse All 28 View Live